Analyst firms · Goldman Sachs · DBVT
Goldman Sachs DBVT price target and rating history
DBV Technologies S.A. (DBVT) · Health Care
Goldman Sachs rates DBV Technologies S.A. (DBVT) Sell with a $7.25 price target, as of its latest action on May 29, 2025. It has published 3 rating actions on DBVT since May 2022, including 0 upgrades and 2 downgrades.
- Current rating
- Sell
- Price target
- $7.25
- Median target, all firms
- Too few
- Actions on DBVT
- 3
Goldman Sachs price target on DBVT
Every Goldman Sachs rating on DBVT
- May 29, 2025
- Dec 16, 2022
- May 10, 2022
How other firms rate DBVT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Cantor Fitzgerald | Overweight | $42 | Dec 15, 2025 |
| Guggenheim | Buy | $35 | Dec 3, 2025 |
Questions about Goldman Sachs and DBVT
- What is Goldman Sachs's price target for DBVT?
- Goldman Sachs's latest stated price target for DBV Technologies S.A. (DBVT) is $7.25, from its action on May 29, 2025.
- What is Goldman Sachs's rating on DBVT?
- Goldman Sachs rates DBVT Sell, a bearish rating, as of May 29, 2025.
- When did Goldman Sachs last change its view on DBVT?
- On May 29, 2025, Goldman Sachs resumes coverage at Sell, price target $7.25.
All Goldman Sachs ratingsDBVT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.